- Immunogenicity and safety of the CoronaVac vaccine in patients underg…
Number of the records: 1  

Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer

  1. SYS0181753
    LBL
      
    00000naa--2200000-a-4500
    005
      
    20250607174825.9
    008
      
    220621s2022----xo-----e------------eng--
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng $b eng
    044
      
    $a xo $c SK
    245
    10
    $a Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer / $c Iriagac Yakup ... [et al.]
    300
      
    $b ilustr., grafy, obr., tab.
    504
      
    $a Bibliogr. odkazy
    504
      
    $a Res. angl.
    650
    12
    $7 sllk_us_auth*d001943 $a nádory prsníka $2 mesh
    650
    22
    $7 sllk_us_auth*d008175 $a nádory pľúc $2 mesh
    650
    22
    $7 sllk_us_auth*d000086663 $a vakcíny proti COVID-19 $x použitie terapeutické $2 mesh
    650
    22
    $7 sllk_us_auth*d007074 $a imunoglobulín G $x analýza $2 mesh
    650
    22
    $7 sllk_us_auth*d000086382 $a COVID-19 $2 mesh
    650
    22
    $7 sllk_us_auth*d017809 $a koniec fatálny $2 mesh
    653
    2-
    $a bezpečnosť a účinnosť vakcíny
    653
    2-
    $a vakcína CoronaVac
    653
    2-
    $a kazuistiky
    700
    1-
    $7 sllk_us_auth*0056164 $a Iriagac, Yakup $4 aut
    773
    0-
    $7 nnas $w sllk_us_cat*0181673 $t Bratislavské lekárske listy $g Vol. 123, no. 6 (2022), s. 401-407 $x 0006-9248 $d Bratislava : AEPress, 2022
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.